Regulation of the cholinergic gene locus

Journal of Physiology Paris

Volumn 92, Issue 2, 1998, Pages 149-152

  Tanaka, Hiromitsu ^a   Shimojo, Masahito ^a   Wu, Donghai ^a   Hersh, Louis B ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Choline acetyltransferase; Coordinate regulation; Protein kinase A; Transcriptional regulation; Vesicular acetylcholine transporter

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; BUCLADESINE; CHOLINE ACETYLTRANSFERASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEOTIDE; VESICULAR ACETYLCHOLINE TRANSPORTER;

CHOLINERGIC SYSTEM; CONFERENCE PAPER; ENHANCER REGION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; OPEN READING FRAME; PROMOTER REGION; REGULATORY MECHANISM; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0032458389     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80154-X     Document Type: Conference Paper

References (15)

1. [1] Chomczynski P., Sacchi N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
2. [2] Correll L.A., Woodford T.A., Corbin J.D., Mellon P.L., McKnight G.S., Functional characterization of cAMP-binding mutations in Type I protein kinase, J. Biol. Chem. 264, (1989) 16672-16678.
3. [3] Erickson J.D., Weihe E., Schafer M.K.-M., Neale E., Williamson L., Bonner T.I., Tao-Cheng J.-H., Eiden L.E., The VAChT/ChAT 'cholinergic gene locus': new aspects of genetic and vesicular regulation of cholinergic function, in: Klein J., Loffelholz K., (Eds.), Progress in Brain Research: Cholinergic Mechanisms: From Molecular Biology to Clinical Significance, Elvsevier, 109, (1996) 69-82.
4. [4] Fonnum F., A rapid radiochemical method for the determination of choline acetyltransferase, J. Neurochem. 24 (1975) 407-409.
5. [5] Ginty D., Glowacka D., De Frano D., Wagner J.A., Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities, J. Biol. Chem. 266 (1991) 15325-15333.
6. [6] Hersh L.B., Induction of choline acetyltransferase in the neuroblastoma x glioma cell line NG108-15, Neurochem. Res. 17 (1992) 1063-1067.
7. [7] Hersh L.B., Kong C.F., Sampson C., Mues G., Li Y.-P., Fisher A., Hilt D., Baetge E.E., Comparison of the promoter region of the human and porcine choline acetyltransferase genes: localization of an important enhancer region, J. Neurochem. 61 (1993) 306-314.
8. [8] Ibanez C.F., Persson H., Localization of sequences determining cell type specificity and NGF responsiveness in the promoter region of the rat choline acetyltransferase gene, Eur. J. Neurosci. 3 (1991) 1309-1315.
9. [9] Inoue H., Baetge E. E., Hersh L.B., Enhancer containing unusual GC box-like sequences on the human choline acetyltransferase gene, Mol. Brain Res. 20 (1993) 299-304.
10. [10] Lonnerberg P., Lendahl U., Funakoshi H., Arhlund-Richter L., Persson H., Ibanez C.F., Regulatory region in choline acetyltransferase gene directs developmental and tissue-specific expression in transgenic mice, Proc. Natl. Acad. Sci. USA 92 (1995) 4046-4050.
11. [11] Lonnerberg P, Schoenherr C.J., Anderson D.J., Ibanez C.F., Cell-type specific regulation of choline acetyltransferase gene expression: Role of the neuron-restrictive silencer element and cholinergic specific enhancer sequences, J. Biol. Chem. 271 (1996) 33358-33365.
12. [12] Misawa H., Takahashi R., Deguchi T., Transcriptional regulation of choline acetyltransferase gene by cyclic AMP, J. Neurochem. 60 (1993) 1383-1387.
13. [13] Naciff J.M., Misawa H., Dedman J.R., Molecular characterization of the mouse vesicular acetylcholine transporter gene, Neuroreport 8 (1997) 3467-3473.
14. [14] Sambrook J., Fritsch E.F., Maniatis T., Molecular Cloning: A Laboratory Manual. 2nd edition, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989.
15. [15] Van Buskirk R., Corcoran T., Wagner J.A., Clonal variants of PC12 pheochromocytoma cells with defects in cAMP-dependent protein kinases induce ornithine decarboxylase in response to nerve growth factor but not to adenosine agonists, Mol. Cell. Biol. 5 (1985) 1984-1992.